表紙
市場調查報告書

全球人工呼吸器市場: 監管情況、分析與預測(2021年∼2030年)

Global Ventilator Market: Regulatory Landscape, Analysis and Forecast, 2021-2030

出版商 BIS Research Inc. 商品編碼 941005
出版日期 內容資訊 英文 278 Pages
商品交期: 最快1-2個工作天內
價格
全球人工呼吸器市場: 監管情況、分析與預測(2021年∼2030年) Global Ventilator Market: Regulatory Landscape, Analysis and Forecast, 2021-2030
出版日期: 2020年05月29日內容資訊: 英文 278 Pages
簡介

預估全球人工呼吸器市場在COVID-19流行之後到2030年底將達32億5,820萬美元。

本報告研究全球人工呼吸器市場,彙整市場機會、成長及阻礙因素,提供按產品類型、形式、病患年齡、末端使用、區域的市場分析,以及競爭情勢、主要企業簡介等情報。

目錄

摘要整理

第1章 產品定義

第2章 研究範圍

  • 研究範圍
  • 報告除外基準
  • 研究報告回答的主要疑問

第3章 研究方法

  • 1次資料來源
  • 2次資料來源
  • 市場預測模式
  • 資料來源分類
  • 企業介紹選擇基準
  • 假設和限制

第4章 市場概要

  • 人工呼吸器概要
  • 全球人工呼吸器安裝基礎
  • 全球人工呼吸器市場情勢

第5章 競爭分析

  • 市場占比分析
    • 全球人工呼吸器市場市場占比分析
    • 全球非侵襲式人工呼吸器市場占比分析
  • 產品MAPPING分析
  • 主要策略和開發
    • 產品核准與發佈
    • 綜效活動(合資、合作、夥伴關係)
    • 資金
    • 產品升級和矯正措施
    • 收購
  • 參與企業類型
    • 醫療保健企業
    • 非醫療保健企業
  • 對企業而言的機會與課題
    • 醫療保健企業
    • 非醫療保健企業
  • 價格分析

第6章 產業分析

  • 專利分析
    • 專利申請趨勢,COVID以前階段(2015年1月∼2020年3月)
  • 監管框架和政府舉措
    • COVID-19以前和COVID-19以後的監管比較
    • 緊急使用授權(EUA)
  • 供需分析
    • 全球供需
    • 組件供應鏈
    • 人工呼吸器成本細項分析

第7章 全球人工呼吸器市場規模與預測

  • 市場動態
    • 成長推動因素
    • 成長阻礙因素
  • 影響分析
  • 成長機會
    • 冠狀病毒爆發導致全球人工呼吸器需求提升
    • 居家照護和緊急使用的便攜式人工呼吸器需求增加
    • 數位教育和培訓工具的發展

第8章 全球人工呼吸器市場(按產品類型)

  • 重症治療用人工呼吸器
  • 便攜式工呼吸器

第9章 全球人工呼吸器市場(按形式)

  • 非侵襲式人工呼吸器
  • 侵襲/機械式人工呼吸器

第10章 全球人工呼吸器市場(按病患年齡)

  • 兒童及新生兒
  • 成人

第11章 全球人工呼吸器市場(按末端使用)

  • 醫院和專門診所
  • 緊急醫療服務
  • 居家照護

第12章 全球人工呼吸器市場(按區域)

  • 北美人工呼吸器市場
    • 北美人工呼吸器市場(按產品類型)
    • 北美人工呼吸器市場(按形式)
    • 北美人工呼吸器市場(按病患年齡)
    • 北美人工呼吸器市場(按末端使用)
    • 北美人工呼吸器市場(按國家)
  • 歐洲人工呼吸器市場
    • 歐洲人工呼吸器市場(按產品類型)
    • 歐洲人工呼吸器市場(按形式)
    • 歐洲人工呼吸器市場(按病患年齡)
    • 歐洲人工呼吸器市場(按末端使用)
    • 歐洲人工呼吸器市場(按國家)
  • 亞太地區人工呼吸器市場
    • 亞太地區人工呼吸器市場(按產品類型)
    • 亞太地區人工呼吸器市場(按形式)
    • 亞太地區人工呼吸器市場(按病患年齡)
    • 亞太地區人工呼吸器市場(末端使用)
    • 亞太地區人工呼吸器市場(按國家)
  • 全球其他地區人工呼吸器市場
    • 全球其他地區人工呼吸器市場(按產品類型)
    • 全球其他地區人工呼吸器市場(按形式)
    • 全球其他地區人工呼吸器市場(按病患年齡)
    • 全球其他地區人工呼吸器市場(按末端使用)

第13章 企業簡介

  • Aerobiosys Innovations Private Limited
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • COVID-19情勢中的Aerobiosys Innovations Private Limited
  • Air Liquide
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Air Liquide Healthcare
  • DrgerwerkAG&Co. KGaA
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的DrgerwerkAG&Co. KGaA
  • General Electric Company
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的GE Healthcare
  • Getinge AB
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Getinge AB
  • Hamilton Medical
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Hamilton Medical
  • Koninklijke Philips NV
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Koninklijke Philips NV
  • LwensteinMedical Innovation GmbH&Co. KG
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的LwensteinMedical Innovation GmbH&Co. KG
  • Medtronic plc
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Medtronic plc
  • OneBreath Inc.
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的OneBreath Inc.
  • Penlon Ltd
    • 企業概要
    • 全球人工呼吸器市場中Penlon Ltd的角色
    • 近期發展
    • COVID-19情勢中的Penlon Ltd
  • ResMed
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的ResMed
  • SCHILLER
    • 企業概要
    • 全球人工呼吸器市場中的角色
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Smiths Group plc
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • COVID-19情勢中的Smiths Medical、Inc.
  • Ventec Life Systems
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Ventec Life Systems
  • Ventinova Medical
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的Ventinova Medical
  • VYAIRE MEDICAL, INC.
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的VYAIRE MEDICAL, INC.
  • WEINMANN Emergency Medical Technology GmbH + Co. KG
    • 企業概要
    • 全球人工呼吸器市場中的角色
    • 近期發展
    • COVID-19情勢中的WEINMANN Emergency Medical Technology GmbH + Co. KG
  • ZOLL Medical Corporation
    • 企業概要
    • 全球人工呼吸器市場的角色
    • 近期發展
    • COVID-19情勢中的ZOLL Medical Corporation
  • 非醫療保健企業
    • Dyson Ltd.
    • Ford Motor Company
    • General Motors Company
    • Maruti Suzuki India Limited
    • Virgin Orbit (Virgin Group子企業)
目錄
Product Code: BH216A

“Global Ventilator Market to Reach $3,258.2 Million by the End of 2030 Post-COVID-19 Pandemic.”

Market Segmentation

  • Product Type - Intensive Care Ventilator and Portable Ventilator
  • Modality - Invasive Ventilation and Non-Invasive Ventilation
  • Patient Age- Adult and Pediatric and Neonates
  • End User - Hospitals and Specialty Clinics, Emergency Medical Services, and Homecare

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, South Korea, Singapore, Australia and New Zealand, Rest-of-Asia-Pacific
  • Rest-of-the-World - Latin America, Middle East and Africa

Growth Drivers

  • Increasing Respiratory Disease Incidences
  • Rising Geriatric Population
  • Increase in Number of ICU Beds
  • High Number of Premature Births
  • Government and Organizational Initiatives to Boost Ventilator Production

Market Challenges

  • Complications and Side-Effects Associated with Ventilator Usage
  • Lack of Trained Medical Staff

Market Opportunities

  • Coronavirus Outbreak Leading to Rising Global Ventilator Demand
  • Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
  • Development of Digital Education and Training Tool

Key Healthcare and Non-Healthcare Companies Profiled

Aerobiosys Innovations Private Limited, Air Liquide, Dragerwerk AG & Co. KGaA, General Electric Company, Getting AB, Hamilton Medical, Koninklijke Philips N.V., Lowenstein Medical Innovation GmbH & Co. KG, Medtronic plc, OneBreath Inc., Penlon Ltd, ResMed, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Group plc, Ventec Life Systems, Ventinova Medical, VYAIRE MEDICAL,INC., WEINMANN Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation

Non-Healthcare Companies

Dyson Ltd, Ford Motor Company, General Motors Company, Maruti Suzuki India Limited, Virgin Orbit

Key Questions Answered:

  • Which country has the maximum number of installed bases of ventilators in the year 2019, and why?
  • What are the major regulatory changes taking place in the global ventilator market pre-COVID-19, during COVID-19, and post-COVID-19? How are these changes expected to impact the global ventilator market in the future?
  • How is the industry expected to evolve during the forecast period 2021-2030?
  • What will be the impact on the products that have been awarded emergency use authorization (EUA) during the COVID-19 pandemic, once the pandemic is over?
  • How has the supply and demand of the ventilator changed during the COVID-19 phase in contrast to the pre-COVID-19 phase?
  • What is the market value estimates of the leading segments of the global ventilator market in 2030?
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What are the major driving factors, challenges, and opportunities for the global ventilator market? What will be the impact of these factors once the COVID-19 pandemic is over?
  • What is the growth potential of the global ventilator market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?

Market Overview

In 2019, the annual global demand for the ventilators was 82,500. However, the accelerated spread of COVID-19 and rising severity of the cases globally has propelled the global demand for ventilators by 5.6 times, up-to 413,000, by the end of 2020. To cope with the rising demand for ventilators, regulatory bodies across different regions, such as the Food and Drug Administration (FDA), Health Canada, and Therapeutics Goods Administration (TGA), have taken unprecedented steps. For instance, in March 2020 FDA declared COVID-19 pandemic as a public emergency and authorized anesthesia gas machines, continuous positive airway pressure (CPAP), and other sleep apnea devices as alternative ventilators under emergency use authorization (EUA). Furthermore, in April 2020, the TGA published a document stating the minimum requirements to be met by medical devices to be used as alternative ventilators.

Moreover, the regulatory bodies are also revamping ventilator supply chains to limit the supply shortage constraints. For instance, under the Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency guidelines, the FDA has authorized the usage of alternative materials for making ventilator tubing. Furthermore, the FDA has also approved modifications to ventilator motor so that other suppliers can manufacture it.

Our healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global ventilator market. Moreover, the global market for ventilators is predicted to grow at an exponential CAGR of 176% by the end of 2020. However, a significant dip is expected in 2021 owing to the overproduction of ventilators and stockpiling of the device. The market is anticipated to normalize from 2022. The market is driven by certain factors, which include the rising incidence of respiratory diseases, high rate of premature births, rising demand for critical care in the geriatric population, and government initiatives for boosting the ventilator production.

The market is favored by the development of low-cost ventilator products and partnerships between healthcare and non-healthcare companies for scaling up the ventilator production.

Within the research report, the market is segmented based on product type, modality, patient age, end user and regional analysis. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Table of Contents

Executive Summary

1. Product Definition

2. Research Scope

  • 2.1. Research Scope
  • 2.2. Exclusion Criteria of the Report
  • 2.3. Key Questions Answered by the Research Study

3. Report Methodology

  • 3.1. Primary Data Sources
  • 3.2. Secondary Data Sources
  • 3.3. Market Estimation Model
  • 3.4. Data Sources Categorization
  • 3.5. Selection Criteria for Company Profiles
  • 3.6. Assumptions and Limitations

4. Market Overview

  • 4.1. Overview of Ventilators
  • 4.2. Global Installed Base of the Ventilators
  • 4.3. Global Ventilator Market Scenario

5. Competitive Analysis

  • 5.1. Market Share Analysis
    • 5.1.1. Market Share Analysis for the Global Mechanical Ventilators Market
    • 5.1.2. Market Share Analysis for the Global Non-Invasive Ventilators Market
  • 5.2. Product Mapping Analysis
  • 5.3. Key Strategies and Developments
    • 5.3.1. Product Approvals and Launches
    • 5.3.2. Synergistic Activities (Joint Ventures, Collaborations, and Partnerships)
    • 5.3.3. Funding
    • 5.3.4. Product Upgradation and Corrective Actions
    • 5.3.5. Acquisitions
  • 5.4. Types of Company Entering the Market
    • 5.4.1. Healthcare Companies
    • 5.4.2. Non-Healthcare Companies
  • 5.5. Opportunities and Challenges for Companies
    • 5.5.1. Healthcare Companies
    • 5.5.2. Non-Healthcare Companies
  • 5.6. Pricing Analysis

6. Industry Analysis

  • 6.1. Patent Analysis
    • 6.1.1. Patent Filling Trend, Pre-COVID Phase (January 2015-March 2020)
  • 6.2. Regulatory Framework and Government Initiatives
    • 6.2.1. Comparison of the Pre-COVID-19 and Post-COVID-19 Regulations
      • 6.2.1.1. Regulations in North America
        • 6.2.1.1.1. Food and Drug Administration (FDA)
        • 6.2.1.1.2. Health Canada
      • 6.2.1.2. Regulations in Europe
      • 6.2.1.3. Regulations in Asia-Pacific
        • 6.2.1.3.1. National Medical Products Administration (NMPA)
        • 6.2.1.3.2. Pharmaceutical and Medical Device Agency (PMDA)
        • 6.2.1.3.3. The Central Drug Standard Control Organization (CDSCO)
        • 6.2.1.3.4. Therapeutic Goods Administration (TGA)
        • 6.2.1.3.5. Health Science Authority (HSA)
      • 6.2.1.4. Regulations in Latin America
    • 6.2.2. Emergency Use Authorization (EUA)
  • 6.3. Supply and Demand Analysis
    • 6.3.1. Global Supply and Demand
      • 6.3.1.1. Pre-COVID
      • 6.3.1.2. Post-COVID
    • 6.3.2. Component Supply Chain
    • 6.3.3. Tear-Down Analysis of Ventilator Costing

7. Global Ventilator Market Sizing and Forecast

  • 7.1. Market Dynamics
    • 7.1.1. Growth Promoting Factors
      • 7.1.1.1. Increasing Respiratory Disease Incidences
      • 7.1.1.2. Rising Geriatric Population
      • 7.1.1.3. Increase in Number of ICU Beds
      • 7.1.1.4. High Number of Premature Births
      • 7.1.1.5. Government and Organizational Initiatives to Boost Ventilator Production
    • 7.1.2. Growth Inhibiting Factors
      • 7.1.2.1. Complications and Side-Effects Associated with Ventilators Usage
      • 7.1.2.2. Lack of Trained Medical Staff
  • 7.2. Impact Analysis
  • 7.3. Growth Opportunities
    • 7.3.1. Coronavirus Outbreak Leading to Rising Global Ventilator Demand
    • 7.3.2. Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
    • 7.3.3. Development of Digital Education and Training Tool

8. Global Ventilator Market (by Product Type)

  • 8.1. Intensive Care Ventilator
  • 8.2. Portable Ventilator

9. Global Ventilator Market (by Modality)

  • 9.1. Non-Invasive Ventilation
  • 9.2. Invasive Ventilation/Mechanical Ventilation

10. Global Ventilator Market (by Patient Age)

  • 10.1. Pediatric and Neonates
  • 10.2. Adult

11. Global Ventilator Market (by End User)

  • 11.1. Hospitals and Specialty Clinics
  • 11.2. Emergency Medical Services
  • 11.3. Homecare

12. Global Ventilator Market (by Region)

  • 12.1. North America Ventilator Market
    • 12.1.1. North America Ventilator Market (by Product Type)
    • 12.1.2. North America Ventilator Market (by Modality)
    • 12.1.3. North America Ventilator Market (by Patient Age)
    • 12.1.4. North America Ventilator Market (by End User)
    • 12.1.5. North America Ventilator Market (by Country)
      • 12.1.5.1. U.S.
        • 12.1.5.1.1. U.S. Ventilator Market (by Product Type)
        • 12.1.5.1.2. U.S. Ventilator Market (by Modality)
        • 12.1.5.1.3. U.S. Ventilator Market (by Patient Age)
        • 12.1.5.1.4. U.S. Ventilator Market (by End User)
      • 12.1.5.2. Canada
        • 12.1.5.2.1. Canada Ventilator Market (by Product Type)
        • 12.1.5.2.2. Canada Ventilator Market (by Modality)
        • 12.1.5.2.3. Canada Ventilator Market (by Patient Age)
        • 12.1.5.2.4. Canada Ventilator Market (by End User)
  • 12.2. Europe Ventilator Market
    • 12.2.1. Europe Ventilator Market (by Product Type)
    • 12.2.2. Europe Ventilator Market (by Modality)
    • 12.2.3. Europe Ventilator Market (by Patient Age)
    • 12.2.4. Europe Ventilator Market (by End User)
    • 12.2.5. Europe Ventilator Market (by Country)
      • 12.2.5.1. Germany
        • 12.2.5.1.1. Germany Ventilator Market (by Product Type)
        • 12.2.5.1.2. Germany Ventilator Market (by Modality)
        • 12.2.5.1.3. Germany Ventilator Market (by Patient Age)
        • 12.2.5.1.4. Germany Ventilator Market (by End User)
      • 12.2.5.2. The U.K.
        • 12.2.5.2.1. The U.K. Ventilator Market (by Product Type)
        • 12.2.5.2.2. The U.K. Ventilator Market (by Modality)
        • 12.2.5.2.3. The U.K. Ventilator Market (by Patient Age)
        • 12.2.5.2.4. The U.K. Ventilator Market (by End User)
      • 12.2.5.3. France
        • 12.2.5.3.1. France Ventilator Market (by Product Type)
        • 12.2.5.3.2. France Ventilator Market (by Modality)
        • 12.2.5.3.3. France Ventilator Market (by Patient Age)
        • 12.2.5.3.4. France Ventilator Market (by End User)
          • 12.2.5.4. Italy
        • 12.2.5.4.1. Italy Ventilator Market (by Product Type)
        • 12.2.5.4.2. Italy Ventilator Market (by Modality)
        • 12.2.5.4.3. Italy Ventilator Market by (Patient Age)
        • 12.2.5.4.4. Italy Ventilator Market (by End User)
      • 12.2.5.5. Spain
        • 12.2.5.5.1. Spain Ventilator Market (by Product Type)
        • 12.2.5.5.2. Spain Ventilator Market (by Modality)
        • 12.2.5.5.3. Spain Ventilator Market (By Patient Age)
        • 12.2.5.5.4. Spain Ventilator Market (by End User)
      • 12.2.5.6. Rest-of-Europe
        • 12.2.5.6.1. Rest-of-Europe Ventilator Market (by Product Type)
        • 12.2.5.6.2. Rest-of-Europe Ventilator Market (by Modality)
        • 12.2.5.6.3. Rest-of-Europe Ventilator Market (by Patient Age)
        • 12.2.5.6.4. Rest-of-Europe Ventilator Market (by End User)
  • 12.3. Asia-Pacific Ventilator Market
    • 12.3.1. Asia-Pacific Ventilator Market (by Product Type)
    • 12.3.2. Asia-Pacific Ventilator Market (by Modality)
    • 12.3.3. Asia-Pacific Ventilator Market (by Patient Age)
    • 12.3.4. Asia-Pacific Ventilator Market (by End User)
    • 12.3.5. Asia-Pacific Ventilator Market, (by Country)
      • 12.3.5.1. China
        • 12.3.5.1.1. China Ventilator Market (by Product Type)
        • 12.3.5.1.2. China Ventilator Market (by Modality)
        • 12.3.5.1.3. China Ventilator Market (by Patient Age)
        • 12.3.5.1.4. China Ventilator Market (by End User)
      • 12.3.5.2. Japan
        • 12.3.5.2.1. Japan Ventilator Market (by Product Type)
        • 12.3.5.2.2. Japan Ventilator Market (by Modality)
        • 12.3.5.2.3. Japan Ventilator Market (by Patient Age)
        • 12.3.5.2.4. Japan Ventilator Market (by End User)
      • 12.3.5.3. India
        • 12.3.5.3.1. India Ventilator Market (by Product Type)
        • 12.3.5.3.2. India Ventilator Market (by Modality)
        • 12.3.5.3.3. India Ventilator Market (by Patient Age)
        • 12.3.5.3.4. India Ventilator Market (by End User)
      • 12.3.5.4. South Korea
        • 12.3.5.4.1. South Korea Ventilator Market (by Product Type)
        • 12.3.5.4.2. South Korea Ventilator Market (by Modality)
        • 12.3.5.4.3. South Korea Ventilator Market (by Patient Age)
        • 12.3.5.4.4. South Korea Ventilator Market (by End User)
      • 12.3.5.5. Singapore
        • 12.3.5.5.1. Singapore Ventilator Market (by Product Type)
        • 12.3.5.5.2. Singapore Ventilator Market (by Modality)
        • 12.3.5.5.3. Singapore Ventilator Market (by Patient Age)
        • 12.3.5.5.4. Singapore Ventilator Market (by End User)
          • 12.3.5.6. Australia and New Zealand
        • 12.3.5.6.1. Australia and New Zealand Ventilator Market (by Product Type)
        • 12.3.5.6.2. Australia and New Zealand Ventilator Market (by Modality)
        • 12.3.5.6.3. Australia and New Zealand Ventilator Market (by Patient Age)
        • 12.3.5.6.4. Australia and New Zealand Ventilator Market (by End User)
          • 12.3.5.7. Rest-of-Asia-Pacific
        • 12.3.5.7.1. Rest-of-Asia-Pacific Ventilator Market (by Product Type)
        • 12.3.5.7.2. Rest- of -Asia-Pacific Ventilator Market (by Modality)
        • 12.3.5.7.3. Rest-of-Asia-Pacific Ventilator Market (by Patient Age)
        • 12.3.5.7.4. Rest-of-Asia-Pacific Ventilator Market (by End User)
  • 12.4. Rest-of-the-World Ventilator Market
    • 12.4.1. Rest-of-the-World Ventilator Market (by Product Type)
    • 12.4.2. Rest-of-the-World Ventilator Market (by Modality)
    • 12.4.3. Rest-of-the-World Ventilator Market (by Patient Age)
    • 12.4.4. Rest-of-the-World Ventilator Market (by End User)

13. Company Profiles

  • 13.1. Aerobiosys Innovations Private Limited
    • 13.1.1. Company Overview
    • 13.1.2. Role of Aerobiosys Innovations Private Limited in the Global Ventilator Market
    • 13.1.3. Aerobiosys Innovations Private Limited in the COVID-19 Scenario
  • 13.2. Air Liquide
    • 13.2.1. Company Overview
    • 13.2.2. Role of Air Liquide in the Global Ventilator Market
    • 13.2.3. Recent Developments
    • 13.2.4. Air Liquide Healthcare in the COVID-19 Scenario
  • 13.3. Drägerwerk AG & Co. KGaA
    • 13.3.1. Company Overview
    • 13.3.2. Role of Drägerwerk AG & Co. KGaA in the Global Ventilator Market
    • 13.3.3. Recent Developments
    • 13.3.4. Drägerwerk AG & Co. KGaA in the COVID-19 Scenario
  • 13.4. General Electric Company
    • 13.4.1. Company Overview
    • 13.4.2. Role of General Electric Company in the Global Ventilator Market
    • 13.4.3. Recent Developments
    • 13.4.4. GE Healthcare in the COVID-19 Scenario
  • 13.5. Getinge AB
    • 13.5.1. Company Overview
    • 13.5.2. Role of Getinge AB in the Global Ventilator Market
    • 13.5.3. Recent Developments
    • 13.5.4. Getinge AB in the COVID-19 Scenario
  • 13.6. Hamilton Medical
    • 13.6.1. Company Overview
    • 13.6.2. Role of Hamilton Medical in the Global Ventilator Market
    • 13.6.3. Recent Developments
    • 13.6.4. Hamilton Medical in the COVID-19 Scenario
  • 13.7. Koninklijke Philips N.V
    • 13.7.1. Company Overview
    • 13.7.2. Role of Koninklijke Philips N.V.in the Global Ventilator Market
    • 13.7.3. Recent Developments
    • 13.7.4. Koninklijke Philips N.V. in the COVID-19 Scenario
  • 13.8. Löwenstein Medical Innovation GmbH & Co. KG
    • 13.8.1. Company Overview
    • 13.8.2. Role of Löwenstein Medical Innovation GmbH & Co. KG in the Global Ventilator Market
    • 13.8.3. Recent Development
    • 13.8.4. Löwenstein Medical Innovation GmbH & Co. KG in the COVID-19 Scenario
  • 13.9. Medtronic plc
    • 13.9.1. Company Overview
    • 13.9.2. Role of Medtronic plc in the Global Ventilator Market
    • 13.9.3. Recent Developments
    • 13.9.4. Medtronic plc in the COVID-19 Scenario
  • 13.10. OneBreath Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Role of OneBreath Inc. in the Global Ventilator Market
    • 13.10.3. Recent Developments
    • 13.10.4. OneBreath Inc. in the COVID-19 Scenario
  • 13.11. Penlon Ltd
    • 13.11.1. Company Overview
    • 13.11.2. Role of Penlon Ltd in the Global Ventilator Market
    • 13.11.3. Recent Developments
    • 13.11.4. Penlon Ltd in the COVID-19 Scenario
  • 13.12. ResMed
    • 13.12.1. Company Overview
    • 13.12.2. Role of ResMed. in the Global Ventilator Market
    • 13.12.3. Recent Developments
    • 13.12.4. ResMed in the COVID-19 Scenario
  • 13.13. SCHILLER
    • 13.13.1. Company Overview
    • 13.13.2. Role of SCHILLER in the Global Ventilator Market
  • 13.14. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 13.14.1. Company Overview
    • 13.14.2. Role of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. in the Global Ventilator Market
    • 13.14.3. Recent Developments
    • 13.14.4. Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • 13.15. Smiths Group plc
    • 13.15.1. Company Overview
    • 13.15.2. Role of Smiths Group plc in the Global Ventilator Market
    • 13.15.3. Smiths Medical, Inc. in the COVID-19 Scenario
  • 13.16. Ventec Life Systems
    • 13.16.1. Company Overview
    • 13.16.2. Role of Ventec Life Systems in the Global Ventilator Market
    • 13.16.3. Recent Developments
    • 13.16.4. Ventec Life Systems in the COVID-19 Scenario
  • 13.17. Ventinova Medical
    • 13.17.1. Company Overview
    • 13.17.2. Role of Ventinova Medical in the Global Ventilator Market
    • 13.17.3. Recent Developments
    • 13.17.4. Ventinova Medical in the COVID-19 Scenario
  • 13.18. VYAIRE MEDICAL, INC.
    • 13.18.1. Company Overview
    • 13.18.2. Role of VYAIRE MEDICAL, INC. in the Global Ventilator Market
    • 13.18.3. Recent Developments
    • 13.18.4. VYAIRE MEDICAL, INC. in the COVID-19 Scenario
  • 13.19. WEINMANN Emergency Medical Technology GmbH + Co. KG
    • 13.19.1. Company Overview
    • 13.19.2. Role of WEINMANN Emergency Medical Technology GmbH + Co. KG in the Global Ventilator Market
    • 13.19.3. Recent Developments
    • 13.19.4. WEINMANN Emergency Medical Technology GmbH + Co. KG in the COVID-19 Scenario
  • 13.20. ZOLL Medical Corporation
    • 13.20.1. Company Overview
    • 13.20.2. Role of ZOLL Medical Corporation in the Global Ventilator Market
    • 13.20.3. Recent Developments:
    • 13.20.4. ZOLL Medical Corporation in the COVID-19 Scenario
  • 13.21. Non-Healthcare Companies
    • 13.21.1. Dyson Ltd.
      • 13.21.1.1 Company Overview
      • 13.21.1.2. Role of Dyson Ltd. in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.2. Ford Motor Company
      • 13.21.2.1. Company Overview
      • 13.21.2.2. Role of Ford Motor Company in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.3. General Motors Company
      • 13.21.3.1. Company Overview
      • 13.21.3.2. Role of General Motor Company in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.4. Maruti Suzuki India Limited
      • 13.21.4.1. Company Overview
      • 13.21.4.2. Role of Maruti Suzuki India Limited in the Global Ventilator Market in the COVID-19 Scenario
    • 13.21.5. Virgin Orbit (Subsidiary of Virgin Group)
      • 13.21.5.1. Company Overview
      • 13.21.5.2. Role of Virgin Orbit in Global Ventilator Market in the COVID-19 Scenario

List of Tables

  • Table 5.1: Features and Price Range of Key Products offered by Companies in the Global Ventilator Market
  • Table 5.2: Heat Map Analysis of Ventilators, (by Modality)
  • Table 5.3: Heat Map Analysis of Ventilators, (by Mode)
  • Table 5.4: Key Products Offered by the Healthcare Companies within the Global Ventilator Market
  • Table 5.5: Companies and their Committed Capacities of Ventilators in the Corona Virus Pandemic
  • Table 6.1: European Commission Medical Device Directives
  • Table 6.2: Federal Agencies of EU Member States
  • Table 6.3: Regulatory Bodies in Asia-Pacific
  • Table 6.4: Traditional and New Source of Component Supply Chain
  • Table 6.5: Price Range and Manufacturers of Ventilator Components
  • Table 7.1: Number of ICU beds in the U.S. (Year-wise)
  • Table 7.2: Top Ten Countries with Highest Premature Births in 2018
  • Table 13.1: Key Features and Price Range of Aerobiosys Innovations Private Limited Ventilator
  • Table 13.2: Key Features and Price Range of Air Liquide Healthcare Ventilators
  • Table 13.3: Key Features and Price Range of Drägerwerk AG & Co. KGaA Ventilators
  • Table 13.4: Key Features and Price Range of GE Healthcare Ventilator
  • Table 13.5: Key Features and Price Range of Getinge AB Ventilators
  • Table 13.6: Key Features and Price Range of Hamilton Medical Ventilators
  • Table 13.7: Key Features and Price Range of Koninklijke Philips N.V. Ventilators
  • Table 13.8: Key Features and Price Range of Löwenstein Medical Innovation GmbH & Co. KG Ventilators
  • Table 13.9: Key Features and Price Range of Medtronic plc Ventilators
  • Table 13.10: Key Features and Price Range of OneBreath Inc. Ventilator
  • Table 13.11: Key Features and Price Range of Penlon Ltd Ventilators
  • Table 13.12: Key Features and Price Range of ResMed. Ventilators
  • Table 13.13: Key Features and Price Range of SCHILLER Ventilators
  • Table 13.14: Key Features and Price Range of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Ventilators
  • Table 13.15: Key Features and Price Range of Smiths Medical, Inc. Ventilator
  • Table 13.16: Key Features and Price Range of Ventec Life Systems Ventilator
  • Table 13.17: Key Features and Price Range of Ventinova Medical Ventilators
  • Table 13.18: Key Features and Price Range of VYAIRE MEDICAL, INC. Ventilators
  • Table 13.19: Key Features and Price Range of WEINMANN Emergency Medical Technology GmbH + Co. KG Ventilators
  • Table 13.20: Key Features and Price Range of ZOLL Medical Corporation Ventilators

List of Figures

  • Figure 1: Percentage of COVID-19 Infected Population Requiring Ventilator
  • Figure 2: Surge in the Demand for Ventilators During COVID-19 Pandemic
  • Figure 3: Increasing Demand for Ventilators in the COVID-19 Scenario
  • Figure 4: Global Ventilator Market (Pre-COVID-19), 2019-2030
  • Figure 5: Global Ventilator Market (Post-COVID-19), 2019-2030
  • Figure 6: Major Companies Ramping-Up Ventilator Production
  • Figure 7: Growth Promoting and Growth Inhibiting Factors of Global Ventilator Market
  • Figure 8: Global Ventilator Market: Regulatory Landscape
  • Figure 9: Global Ventilator Market: Patent Analysis (by Year of Filling, January 2015-March 2020
  • Figure 10: Global Ventilator Market (Product Type), 2019 and 2030
  • Figure 11: Global Ventilator Market (by Modality), 2019 and 2030
  • Figure 12: Global Ventilator Market (by End User), 2019 and 2030
  • Figure 13: Global Ventilator Market (by Region), 2019
  • Figure 2.1: Global Ventilator Market Segmentation
  • Figure 3.1: Global Ventilator Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
  • Figure 3.6: Total Number of Healthcare Company Profiles
  • Figure 3.7: Total Number of Non-Healthcare Company Profiles
  • Figure 3.8: Assumptions and Limitations
  • Figure 4.1: Coronavirus (Spread, Symptoms, Susceptibility, Preventive Measures)
  • Figure 4.2: Installed Base of Ventilators, 2019
  • Figure 4.3: Global Availability of Ventilators Per Million Population, 2019
  • Figure 4.4: Market Landscape of Global Ventilator Market
  • Figure 5.1: Global Ventilators Market Share Analysis, (Mechanical), 2019
  • Figure 5.2: Global Ventilators Market Share Analysis, (Non-Invasive), 2019
  • Figure 5.3: Companies with Highest Share of Ventilators Compatible for all Age-Group Usage (Top Three Companies)
  • Figure 5.4: Companies with Highest Share of Homecare Ventilators (Top Three Companies)
  • Figure 5.5: Companies Offering Highest Number of Portable Ventilators (Top Three Companies)
  • Figure 5.6: Global Ventilator Market, (by Key Development and Strategy), January 2016-March 2020
  • Figure 5.7: Global Ventilator Market, (Product Approvals and Launches), January 2016-March 2020
  • Figure 5.8: Global Ventilator Market, (Synergistic Activities: Joint Ventures, Collaborations, and Partnerships), January 2016-March 2020
  • Figure 5.9: Global Ventilator Market, (Funding), January 2016-March 2020
  • Figure 5.10: Global Ventilator Market, (Product Upgradation and Corrective Actions), January 2016-March 2020
  • Figure 5.11: Global Ventilator Market, (Acquisition), January 2016-March 2020
  • Figure 5.12: Major Companies Ramping-Up the Ventilator Production
  • Figure 5.13: Major Challenges in Ramping-Up Production and Possible Solutions
  • Figure 5.14: Opportunities and Challenges for the Healthcare Companies
  • Figure 5.15: Opportunities and Challenges for the Non-Healthcare Companies
  • Figure 5.16: Price Range of Products Offered by Key Players in the Global Ventilator Market
  • Figure 5.17: Global Ventilator Pricing Trend ($), 2015-2019
  • Figure 6.1: Global Ventilator Market: Patent Analysis (by Year of Filling, January 2015-March 2020)
  • Figure 6.2: Risk Assessment of Medical Devices
  • Figure 6.3: Global Ventilator Market: Regulatory Landscape
  • Figure 6.4: FDA Regulatory Pathway for Medical Device
  • Figure 6.5: FDA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.6: Health Canada Regulatory Pathway for Medical Device
  • Figure 6.7: Health Canada Regulations Modification: Pre-COVID-19 Phase to Post COVID-19 Phase
  • Figure 6.8: EU Regulatory Pathway for Medical Device
  • Figure 6.9: European Commission Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.10: NMPA Regulatory Pathway for Medical Device
  • Figure 6.11: NMPA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.12: PMDA Regulatory Pathway for Medical Device
  • Figure 6.13: PMDA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.14: CDSCO Regulatory Pathway for Medical Device
  • Figure 6.15: CDSCO Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.16: TGA Regulatory Pathway for Medical Device
  • Figure 6.17: TGA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.18: HSA Regulatory Pathway for Medical Device
  • Figure 6.19: HSA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
  • Figure 6.20: Emergency Use Procedures During COVID-19
  • Figure 6.21: Value Chain for Ventilators
  • Figure 6.22: Demand-Supply Gap in Ventilators (by June End)
  • Figure 7.1: Prevalence of COPD and Asthma in Key Countries, 2015-2017
  • Figure 7.2: Rising Number of Respiratory Infections in the COVID-19 Pandemic
  • Figure 7.3: Pre-COVID-19 and Post-COVID-19 Demand Surge of Ventilators
  • Figure 7.4: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
  • Figure 7.5: Post-COVID Impact on Geriatric Population
  • Figure 7.6: Capacity Gap of ICU Beds Post-COVID-19
  • Figure 7.7: Regulatory Scenario in Pre-COVID-19 and Post-COVID-19 Situation
  • Figure 7.8: Scenario of Ventilator-Associated Pneumonia in Pre-COVID-19 and During-COVID
  • Figure 7.9: Scenario of Trained Medical Staff in Pre-COVID-19 and During-COVID-19
  • Figure 7.10: Impact Analysis: Growth Promoting Factors and Inhibiting Factors
  • Figure 7.11: Impact on Mortality Rate with Respect to Ventilator Availability
  • Figure 7.12: Features and Benefits of Ventilator Training Alliance Universal Platform
  • Figure 8.1: Global Ventilator Market (by Product Type)
  • Figure 8.2: Global Ventilator Market (by Product Type) 2019-2030
  • Figure 8.3: Global Intensive Care Ventilator Market, 2019-2030
  • Figure 8.4: Global Portable Ventilator Market, 2019-2030
  • Figure 9.1: Global Ventilator Market (by Modality)
  • Figure 9.2: Global Ventilator Market (by Modality), 2019-2030
  • Figure 9.3: Global Non-Invasive Ventilation Market, 2019-2030
  • Figure 9.4: Global Invasive/Mechanical Ventilation Market, 2019-2030
  • Figure 10.1: Global Ventilator Market (by Patient Age)
  • Figure 10.2: Global Ventilator Market (by Patient Age), 2019-2030
  • Figure 10.3: Global Ventilator Market for Pediatric and Neonates, 2019-2030
  • Figure 10.4: Global Ventilator Market for Adult, 2019-2030
  • Figure 11.1: Global Ventilator Market (by End User)
  • Figure 11.2: Global Ventilator Market (by End User), 2019-2030
  • Figure 11.3: Global Ventilator Market in Hospitals and Speciality Clinics, 2019-2030
  • Figure 11.4: Global Ventilator Market in Emergency Medical Services, 2019-2030
  • Figure 11.5: Global Ventilator Market in Homecare, 2019-2030
  • Figure 12.1: Global Ventilator Market (by Region), 2019
  • Figure 12.2: Global Ventilator Market (by Region), 2019-2030
  • Figure 12.3: North America Ventilator Market, 2019-2030
  • Figure 12.4: North America: Market Dynamics
  • Figure 12.5: North America Ventilator Market (by Product Type), 2019-2030
  • Figure 12.6: North America Ventilator Market (by Modality), 2019-2030
  • Figure 12.7: North America Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.8: North America Ventilator Market (by End User), 2019-2030
  • Figure 12.9: North America Ventilator Market (by Country), 2019 and 2030
  • Figure 12.10: U.S. Ventilator Market, 2019-2030
  • Figure 12.11: FDA Action Timeline for COVID-19
  • Figure 12.12: U.S. Ventilator Market (by Product Type), 2019-2030
  • Figure 12.13: U.S. Ventilator Market (by Modality), 2019-2030
  • Figure 12.14: U.S. Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.15: U.S. Ventilator Market (by End User), 2019-2030
  • Figure 12.16: Canada Ventilator Market, 2019-2030
  • Figure 12.17: Canada Ventilator Market (by Product Type), 2019-2030
  • Figure 12.18: Canada Ventilator Market (by Modality), 2019-2030
  • Figure 12.19: Canada Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.20: Canada Ventilator Market (by End User), 2019-2030
  • Figure 12.21: Europe Ventilator Market, 2019-2030
  • Figure 12.22: Europe: Market Dynamics
  • Figure 12.23: Europe Ventilator Market (by Modality), 2019-2030
  • Figure 12.24: Europe Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.25: Europe Ventilator Market (by End User), 2019-2030
  • Figure 12.26: Europe Ventilator Market (by Country), 2019 and 2030
  • Figure 12.27: Germany Ventilator Market, 2019-2030
  • Figure 12.28: Germany Ventilator Market (by Product Type), 2019-2030
  • Figure 12.29: Germany Ventilator Market (by Modality), 2019-2030
  • Figure 12.30: Germany Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.31: Germany Ventilator Market (by End User), 2019-2030
  • Figure 12.32: U.K. Ventilator Market, 2019-2030
  • Figure 12.33: MHRA Action Timeline Amidst COVID-19 Pandemic
  • Figure 12.34: The U.K. Ventilator Market (by Product Type), 2019-2030
  • Figure 12.35: The U.K. Ventilator Market (by Modality), 2019-2030
  • Figure 12.36: The U.K. Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.37: The U.K. Ventilator Market (by End User), 2019-2030
  • Figure 12.38: France Ventilator Market, 2019-2030
  • Figure 12.39: France Ventilator Market (by Product Type), 2019-2030
  • Figure 12.40: France Ventilator Market (by Modality), 2019-2030
  • Figure 12.41: France Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.42: France Ventilator Market (by End User), 2019-2030
  • Figure 12.43: Italy Ventilator Market, 2019-2030
  • Figure 12.44: Italy Ventilator Market (by Product Type), 2019-2030
  • Figure 12.45: Italy Ventilator Market (by Modality), 2019-2030
  • Figure 12.46: Italy Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.47: Italy Ventilator Market (by End User), 2019-2030
  • Figure 12.48: Spain Ventilator Market, 2019-2030
  • Figure 12.49: Spain Ventilator Market (by Product Type), 2019-2030
  • Figure 12.50: Spain Ventilator Market (by Modality), 2019-2030
  • Figure 12.51: Spain Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.52: Spain Ventilator Market (by End User), 2019-2030
  • Figure 12.53: Rest-of-Europe Ventilator Market, 2019-2030
  • Figure 12.54: Rest-of-Europe Ventilator Market (by Product Type), 2019-2030
  • Figure 12.55: Rest-of-Europe Ventilator Market (by Modality), 2019-2030
  • Figure 12.56: Rest-of-Europe Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.57: Rest-of-Europe Ventilator Market (by End User), 2019-2030
  • Figure 12.58: Asia-Pacific Ventilator Market, 2019-2030
  • Figure 12.59: Asia-Pacific: Market Dynamics
  • Figure 12.60: Asia-Pacific Ventilator Market (by Product Type), 2019-2030
  • Figure 12.61: Asia-Pacific Ventilator Market (by Modality), 2019-2030
  • Figure 12.62: Asia-Pacific Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.63: Asia-Pacific Ventilator Market (by End User), 2019-2030
  • Figure 12.64: Asia-Pacific Ventilator Market (by Country), 2019 and 2030
  • Figure 12.65: China Ventilator Market, 2019-2030
  • Figure 12.66: China Ventilator Market (by Product Type), 2019-2030
  • Figure 12.67: China Ventilator Market (by Modality), 2019-2030
  • Figure 12.68: China Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.69: China Ventilator Market (by End User), 2019-2030
  • Figure 12.70: Japan Ventilator Market, 2019-2030
  • Figure 12.71: Japan Ventilator Market (by Product Type), 2019-2030
  • Figure 12.72: Japan Ventilator Market (by Modality), 2019-2030
  • Figure 12.73: Japan Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.74: Japan Ventilator Market (by End User), 2019-2030
  • Figure 12.75: India Ventilator Market, 2019-2030
  • Figure 12.76: Regulatory Workflow for Importing Medical Devices
  • Figure 12.77: India Ventilator Market (by Product Type), 2019-2030
  • Figure 12.78: India Ventilator Market (by Modality), 2019-2030
  • Figure 12.79: India Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.80: India Ventilator Market (by End User), 2019-2030
  • Figure 12.81: South Korea Ventilator Market, 2019-2030
  • Figure 12.82: South Korea Ventilator Market (by Product Type), 2019-2030
  • Figure 12.83: South Korea Ventilator Market (by Modality), 2019-2030
  • Figure 12.84: South Korea Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.85: South Korea Ventilator Market (by End User), 2019-2030
  • Figure 12.86: Singapore Ventilator Market, 2019-2030
  • Figure 12.87: Singapore Ventilator Market (by Product Type), 2019-2030
  • Figure 12.88: Singapore Ventilator Market (by Modality), 2019-2030
  • Figure 12.89: Singapore Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.90: Singapore Ventilator Market (by End User), 2019-2030
  • Figure 12.91: Australia and New Zealand Ventilator Market, 2019-2030
  • Figure 12.92: Australia and New Zealand Ventilator Market (by Product Type), 2019-2030
  • Figure 12.93: Australia and New Zealand Ventilator Market (by Modality), 2019-2030
  • Figure 12.94: Australia and New Zealand Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.95: Australia and New Zealand Ventilator Market (by End User), 2019-2030
  • Figure 12.96: Rest-of-Asia-Pacific Ventilator Market, 2019-2030
  • Figure 12.97: Rest-of-Asia-Pacific Ventilator Market (by Product Type), 2019-2030
  • Figure 12.98: Rest-of-Asia-Pacific Ventilator Market (by Modality), 2019-2030
  • Figure 12.99: Rest-of-Asia-Pacific Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.100: Rest-of-Asia-Pacific Ventilator Market (by End User), 2019-2030
  • Figure 12.101: Rest-of-the-World Ventilator Market, 2019-2030
  • Figure 12.102: Rest-of-the-World: Market Dynamics
  • Figure 12.103: Rest-of-the-World Ventilator Market (by Product Type), 2019-2030
  • Figure 12.104: Rest-of-the-World Ventilator Market (by Modality), 2019-2030
  • Figure 12.105: Rest-of-the-World Ventilator Market (by Patient Age), 2019-2030
  • Figure 12.106: Rest-of-the-World Ventilator Market (by End User), 2019-2030
  • Figure 13.1: Aerobiosys Innovations Private Limited: Overall Product Portfolio
  • Figure 13.2: Air Liquide: Overall Product Portfolio
  • Figure 13.3: Drägerwerk AG & Co. KGaA: Overall Product Portfolio
  • Figure 13.4: GE Healthcare: Overall Product Portfolio
  • Figure 13.5: Getinge AB: Overall Product Portfolio
  • Figure 13.6: Hamilton Medical: Overall Product Portfolio
  • Figure 13.7: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 13.8: Löwenstein Medical Innovation GmbH & Co. KG: Overall Product Portfolio
  • Figure 13.9: Medtronic plc: Overall Product Portfolio
  • Figure 13.10: OneBreath Inc.: Overall Product Portfolio
  • Figure 13.11: Penlon Ltd: Overall Product Portfolio
  • Figure 13.12: ResMed.: Overall Product Portfolio
  • Figure 13.13: SCHILLER: Overall Product Portfolio
  • Figure 13.14: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Overall Product Portfolio
  • Figure 13.15: Smiths Group plc.: Overall Product Portfolio
  • Figure 13.16: Ventec Life Systems.: Overall Product Portfolio
  • Figure 13.17: Ventinova Medical: Overall Product Portfolio
  • Figure 13.18: VYAIRE MEDICAL, INC.: Overall Product Portfolio
  • Figure 13.19: WEINMANN Emergency Medical Technology GmbH + Co. KG: Overall Product Portfolio
  • Figure 13.20: ZOLL Medical Corporation: Overall Product Portfolio